Indivior Total Liabilities 2012-2025 | INDV

Indivior total liabilities from 2012 to 2025. Total liabilities can be defined as the total value of all possible claims against the corporation.
Indivior Annual Total Liabilities
(Millions of US $)
2024 $1,668
2023 $1,951
2022 $1,718
2021 $1,629
2020 $1,449
2019 $1,443
2018 $1,481
2017 $1,647
2016 $1,504
2015 $1,216
2014 $1,222
2013 $492
2012 $412
2011 $305
Indivior Quarterly Total Liabilities
(Millions of US $)
2025-03-31 $1,660
2024-12-31 $1,652
2024-09-30 $1,631
2024-06-30 $1,656
2024-03-31 $1,443
2023-12-31 $1,951
2023-09-30 $1,876
2023-06-30 $1,614
2023-03-31 $1,683
2022-12-31 $1,718
2022-09-30 $1,444
2022-06-30 $1,490
2022-03-31 $1,492
2021-12-31 $1,629
2021-09-30 $1,539
2021-06-30 $1,438
2021-03-31 $1,447
2020-12-31 $1,449
2020-09-30 $1,467
2020-06-30 $1,493
2020-03-31 $1,473
2019-12-31 $1,443
2019-09-30 $1,338
2019-06-30 $1,363
2019-03-31 $1,472
2018-12-31 $1,481
2018-09-30 $1,507
2018-06-30 $1,625
2018-03-31 $1,600
2017-12-31 $1,647
2017-09-30 $1,441
2017-06-30 $1,462
2017-03-31 $1,436
2016-12-31 $1,504
2016-09-30 $1,471
2016-06-30 $1,240
2016-03-31 $1,253
2015-12-31 $1,216
2015-09-30 $1,267
2015-06-30 $1,292
2015-03-31 $0
2014-12-31
2014-09-30 $0
2014-06-30 $0
2013-12-31 $492
2012-12-31 $412
2011-12-31 $305
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.577B $1.188B
Indivior PLC operates as a specialty pharmaceutical company. It is engaged in discovering and developing medications and treatment for alcohol addiction, opioid overdose, cocaine intoxication and co-occurring conditions, such as schizophrenia. The Company markets and promotes SUBOXONE (buprenorphine and naloxone) Sublingual Film, SUBOXONE (buprenorphine and naloxone) Sublingual Tablet, and SUBUTEX (buprenorphine) Sublingual Tablet, each buprenorphine-based treatment for opioid. Indivior PLC is based in United States.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.830B 32.20
Zoetis (ZTS) United States $72.858B 27.18
Daiichi Sankyo, - (DSNKY) Japan $48.987B 24.92
Takeda Pharmaceutical (TAK) Japan $45.406B 9.03
Sandoz Group AG (SDZNY) Switzerland $21.173B 0.00
Summit Therapeutics (SMMT) United States $18.114B 0.00
Merck (MKKGY) Germany $17.092B 12.52
United Therapeutics (UTHR) United States $13.964B 12.35
Shionogi (SGIOY) Japan $13.347B 13.37
Neurocrine Biosciences (NBIX) United States $12.169B 41.68
IPSEN (IPSEY) France $9.836B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $8.083B 65.71
Stevanato Group S.p.A (STVN) Italy $7.365B 45.04
Madrigal Pharmaceuticals (MDGL) United States $6.500B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.528B 0.00
Ionis Pharmaceuticals (IONS) United States $5.486B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.777B 14.53
Soleno Therapeutics (SLNO) United States $3.782B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.010B 10.55
Crinetics Pharmaceuticals (CRNX) United States $2.937B 0.00
Hypermarcas (HYPMY) Brazil $2.857B 18.79
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.326B 12.58
BioCryst Pharmaceuticals (BCRX) United States $2.162B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.125B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.850B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.764B 0.00
Guardian Pharmacy Services (GRDN) United States $1.677B 0.00
Evotec AG (EVO) Germany $1.445B 0.00
ARS Pharmaceuticals (SPRY) United States $1.407B 0.00
Dyne Therapeutics (DYN) United States $1.403B 0.00
Ocular Therapeutix (OCUL) United States $1.211B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.121B 22.43
Harrow (HROW) United States $1.030B 0.00
Ardelyx (ARDX) United States $1.000B 0.00
Collegium Pharmaceutical (COLL) United States $0.963B 5.19
Avadel Pharmaceuticals (AVDL) Ireland $0.906B 0.00
Enliven Therapeutics (ELVN) United States $0.853B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.767B 0.00
AleAnna (ANNA) United States $0.669B 0.00
KalVista Pharmaceuticals (KALV) United States $0.609B 0.00
Xencor (XNCR) United States $0.579B 0.00
Bioventus (BVS) United States $0.574B 14.56
USANA Health Sciences (USNA) United States $0.559B 12.16
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.545B 0.00
Savara (SVRA) United States $0.542B 0.00
Relay Therapeutics (RLAY) United States $0.523B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
CytoDyn (CYDY) United States $0.485B 0.00
Altimmune (ALT) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.473B 0.00
Zevra Therapeutics (ZVRA) United States $0.471B 0.00
Siga Technologies (SIGA) United States $0.443B 9.25
Tourmaline Bio (TRML) United States $0.416B 0.00
Organogenesis (ORGO) United States $0.414B 0.00
Verve Therapeutics (VERV) United States $0.411B 0.00
Oruka Therapeutics (ORKA) United States $0.398B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.360B 9.72
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.85
Aquestive Therapeutics (AQST) United States $0.237B 0.00
ProKidney (PROK) United States $0.232B 0.00
MediWound (MDWD) Israel $0.226B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.219B 0.00
Wellgistics Health (WGRX) United States $0.191B 0.00
OmniAb (OABI) United States $0.188B 0.00
Nanobiotix S.A (NBTX) France $0.181B 0.00
Esperion Therapeutics (ESPR) United States $0.180B 0.00
4D Molecular Therapeutics (FDMT) United States $0.178B 0.00
Avita Medical (RCEL) United States $0.177B 0.00
Liminatus Pharma (LIMN) $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Korro Bio (KRRO) United States $0.152B 0.00
Profound Medical (PROF) Canada $0.151B 0.00
Inhibikase Therapeutics (IKT) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.146B 0.00
Aldeyra Therapeutics (ALDX) United States $0.141B 0.00
Protara Therapeutics (TARA) United States $0.134B 0.00
Larimar Therapeutics (LRMR) United States $0.132B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.130B 0.00
Nektar Therapeutics (NKTR) United States $0.128B 0.00
Lyell Immunopharma (LYEL) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lexeo Therapeutics (LXEO) United States $0.117B 0.00
VAXART, INC (VXRT) United States $0.116B 0.00
Achieve Life Sciences (ACHV) Canada $0.113B 0.00
Cassava Sciences (SAVA) United States $0.108B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.106B 0.00
Fractyl Health (GUTS) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.093B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Champions Oncology (CSBR) United States $0.086B 14.09
Galectin Therapeutics (GALT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Dominari Holdings (DOMH) United States $0.077B 0.00
Inotiv (NOTV) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 55.89
Pyxis Oncology (PYXS) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.073B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Unicycive Therapeutics (UNCY) United States $0.072B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.055B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.051B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.048B 0.00
Karyopharm Therapeutics (KPTI) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
DURECT (DRRX) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.68
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00